Dynagen (Cucurbita pepo)

Dynagen is a standardized extract from Cucurbita pepo (pumpkin) seeds containing 92.84% fatty acids and 0.38% plant sterols. The extract may support prostate health through its beta-sitosterol content and fatty acid profile, though clinical evidence remains preliminary.

Origin & History

Dynagen is a branded extract derived from Cucurbita pepo (pumpkin) seeds, specifically from cultivars like the Moscata variety native to Europe and the Americas. The extraction involves a multi-stage process including initial milling at -5°C, optional supercritical CO₂ pre-extraction, exhaustive methylene chloride extraction, and countercurrent purification, yielding an oily extract standardized to 0.38% total sterols and 92.84% fatty acids.

Historical & Cultural Context

No historical or traditional medicine context for Dynagen or Cucurbita pepo seeds is described in the available sources. The patent focuses solely on modern extraction methods without referencing traditional systems or historical use.

Health Benefits

• May support prostate health based on pharmacological screening (evidence: preliminary, no human trials available)
• Contains plant sterols (0.38%) that are structurally similar to compounds studied for urinary function (evidence: preliminary)
• Rich in fatty acids (92.84%) including linoleic acid identified via GC-MS analysis (evidence: chemical characterization only)
• Allergen-reduced formulation through supercritical CO₂ purification process (evidence: manufacturing claim, no clinical validation)
• Potential cosmetic applications at 0.1-2% in topical formulations (evidence: patent suggestion only)

How It Works

Dynagen's plant sterols, particularly beta-sitosterol, may inhibit 5-alpha-reductase enzyme activity, potentially reducing dihydrotestosterone (DHT) production. The high linoleic acid content (primary fatty acid component) may modulate inflammatory pathways through prostaglandin synthesis. These mechanisms could theoretically support prostate tissue health and urinary function.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Dynagen or Cucurbita pepo seed extracts in the available research. Evidence is limited to patent-described pharmacological screening for prostatic disorders without published trial details, and phytochemical characterization studies showing presence of steroids, alkaloids, and saponins.

Clinical Summary

Current evidence for Dynagen is limited to preliminary pharmacological screening studies with no published human clinical trials available. The 0.38% plant sterol content is significantly lower than concentrations used in prostate health studies with other botanical extracts. While the 92.84% fatty acid profile shows promise based on biochemical analysis, human efficacy data is lacking. More rigorous clinical research is needed to establish therapeutic benefits.

Nutritional Profile

Dynagen (Cucurbita pepo) is a concentrated pumpkin seed-derived ingredient with a high fatty acid content of 92.84% total lipids, dominated by linoleic acid (omega-6 polyunsaturated fatty acid) as confirmed by GC-MS analysis, with likely accompanying oleic acid (monounsaturated) and palmitic acid (saturated) based on typical Cucurbita pepo seed oil composition. Plant sterols are present at 0.38%, primarily delta-7-sterols characteristic of pumpkin seed (delta-7-stigmasterol, delta-7-avenasterol, and spinasterol), which are structurally distinct from the more common beta-sitosterol found in other plant sources. Protein content is not characterized in available data but whole pumpkin seed typically contains 25-35% protein; concentration in this extract is likely reduced given the high lipid fraction. Micronutrient data is limited, though pumpkin seed origin suggests potential presence of magnesium, zinc, and manganese at trace levels. Fiber content is not documented for this extract. Tocopherols (vitamin E isomers, particularly gamma-tocopherol) are likely present as natural antioxidants within the lipid fraction at low concentrations, consistent with Cucurbita pepo seed oil. The allergen-reduced formulation suggests processing steps that may alter native protein profiles, potentially improving bioavailability of lipid-soluble compounds by reducing protein-lipid binding. Bioavailability of plant sterols is inherently low (estimated 0.5-2% absorption) but may be enhanced by the surrounding fatty acid matrix.

Preparation & Dosage

No clinically studied dosage ranges are available for Dynagen. Patent suggests cosmetic use at 0.1-2% in formulations, but this lacks clinical validation. The extract is standardized to approximately 0.38% total sterols and 93% fatty acids post-purification. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Saw Palmetto, Beta-Sitosterol, Pygeum, Zinc, Lycopene

Safety & Interactions

No specific safety data exists for Dynagen as a standardized extract. Pumpkin seed preparations are generally well-tolerated, with occasional mild gastrointestinal upset reported. Potential interactions with blood-thinning medications may occur due to fatty acid content. Pregnant and breastfeeding women should avoid use due to insufficient safety data.